Expansion of pharmaceutical unit; HC notice to Puducherry govt Medical Dialogues Bureau8 May 2018 11:28 AM ISTChennai: The Madras High Court has issued notice to the Puducherry government on a PIL seeking direction to halt the proposed expansion of a...
Latest bid for India's Fortis "more risky", says Manipal CEO Medical Dialogues Bureau8 May 2018 11:09 AM ISTIndia's privately held Manipal Hospitals had to take a "more risky" approach in its latest bid for domestic rival Fortis Healthcare to see off rival...
TPG-Backed Manipal Revises Bid for Fortis Medical Dialogues Bureau7 May 2018 11:44 AM IST(Bloomberg Report)- Fortis Healthcare Ltd. received a revised takeover offer from its first suitor, an Indian company backed by private equity firm...
China removes import duties on 28 medicines; India to get boost Ruby Khatun Khatun6 May 2018 11:30 AM ISTNew Delhi: China on Thursday said it has removed import duties on as many as 28 medicines, including all cancer drugs, from May 1, a move which would...
Glenmark says clinical trial suspended at Jaipur hospital Ruby Khatun Khatun5 May 2018 2:46 PM ISTNew Delhi: Drug firm Glenmark Pharmaceuticals said it has suspended the clinical trial at the Malpani Hospital in Jaipur as soon as it became aware of...
Biocon gets 7 USFDA observations for Bengaluru drug facility Ruby Khatun Khatun4 May 2018 11:00 AM ISTNew Delhi: Biotechnology major Biocon said the US health regulator has made seven observations after inspection of its sterile drug product...
Manipal-led bid for Fortis faces objections: Sources Ruby Khatun Khatun3 May 2018 3:32 PM ISTMUMBAI: Two major investors in Fortis Healthcare, who have concerns over the bidding process for the cash-strapped Indian hospital operator, plan to...
Cipla gets USFDA approval for generic equivalents of Vazculep, Aromasin Ruby Khatun Khatun3 May 2018 10:10 AM ISTNew Delhi: Drug major Cipla has received final approval from the US health regulator for the generic equivalent of Avadel's Vazculep, West Ward Pharm...
Fortis Update: 2 Bidders Raise Offers to Rs 175, Rs 176 per share Ruby Khatun Khatun2 May 2018 11:27 AM ISTNew Delhi: The race to acquire Fortis Healthcare has heated up with two suiters raising their offer prices for the company on the last day of the...
Government to demarcate stem cell therapy from stem cell drug Ruby Khatun Khatun1 May 2018 10:59 AM ISTNew Delhi: To ensure unhindered access of 'stem cell therapy' for treatment by physicians, the Union Health Ministry has proposed to statutory...
Govt brings ISIS drug Tramadol under narcotics law regulation Ruby Khatun Khatun30 April 2018 12:50 PM ISTNew Delhi: Tramadol, a painkiller pharma drug, has been declared a "psychotropic substance" by the Union government and its sale in the country will...
Import banned, Only public sector to manufacture oxytocin Ruby Khatun Khatun29 April 2018 12:32 PM ISTNew Delhi: As part of its efforts to check the misuse of oxytocin by dairy operators and some farmers, the Ministry of Health has restricted its...
